DE3267350D1 - 5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them - Google Patents

5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them

Info

Publication number
DE3267350D1
DE3267350D1 DE8282301023T DE3267350T DE3267350D1 DE 3267350 D1 DE3267350 D1 DE 3267350D1 DE 8282301023 T DE8282301023 T DE 8282301023T DE 3267350 T DE3267350 T DE 3267350T DE 3267350 D1 DE3267350 D1 DE 3267350D1
Authority
DE
Germany
Prior art keywords
trinor
inter
pharmaceutical compositions
compositions containing
phenylene pgi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282301023T
Other languages
English (en)
Inventor
Kiyotaka Ohno
Hiroshi Nagase
Mamoru Ishikawa
Kazuhisa Matsumoto
Shintaro Nishio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of DE3267350D1 publication Critical patent/DE3267350D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/17—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds
    • C07C29/172—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds with the obtention of a fully saturated alcohol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE8282301023T 1981-03-03 1982-03-01 5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them Expired DE3267350D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2935781A JPS57144276A (en) 1981-03-03 1981-03-03 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative

Publications (1)

Publication Number Publication Date
DE3267350D1 true DE3267350D1 (en) 1985-12-19

Family

ID=12273939

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282301023T Expired DE3267350D1 (en) 1981-03-03 1982-03-01 5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them

Country Status (7)

Country Link
US (2) US4564620A (de)
EP (1) EP0060640B1 (de)
JP (1) JPS57144276A (de)
AU (1) AU560140B2 (de)
DE (1) DE3267350D1 (de)
DK (1) DK84082A (de)
ZA (1) ZA821403B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144276A (en) * 1981-03-03 1982-09-06 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
JPS59134787A (ja) * 1983-01-19 1984-08-02 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体の製造法
JPS59161371A (ja) * 1983-03-04 1984-09-12 Toray Ind Inc （−）−〔７−ブロモ−３ａ，８ｂ−シス−ジヒドロ−３Ｈ−シクロペンタ〔ｂ〕ベンゾフラン−５−イル〕ギ酸の製造法
EP0232776B1 (de) * 1986-01-24 1990-10-24 Toray Industries, Inc. 2,5,6,7-Tetranor-4,8-inter-M-phenylen-PGI2-Derivate
WO1988001612A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
WO1988001613A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine, and processes and intermediates therefor
JPH0662599B1 (de) * 1987-10-16 1994-08-17 Toray Industries
US5401768A (en) * 1987-10-16 1995-03-28 Toray Industries, Inc. 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2, derivative, manufacturing process thereof and its use
US5185464A (en) * 1989-02-21 1993-02-09 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5136020A (en) * 1989-02-21 1992-08-04 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5248820A (en) * 1989-02-21 1993-09-28 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
DE69008851T2 (de) * 1989-02-27 1994-08-18 Toray Industries VERFAHREN ZUR HERSTELLUNG VON 5,6,7, -TRINOR- 4,8,-INTER-m-PHENYLEN PGI,2 Abkömmlingen.
ATE98239T1 (de) * 1989-03-14 1993-12-15 Toray Industries 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2derivate.
JP3230246B2 (ja) * 1991-04-11 2001-11-19 東レ株式会社 悪性腫瘍転移抑制剤
US5496850A (en) * 1991-04-11 1996-03-05 Toray Industries, Inc. Antimetastasis agent of malignant tumors
JP3102141B2 (ja) * 1992-05-29 2000-10-23 東レ株式会社 養毛育毛剤
JPH07126161A (ja) * 1993-10-29 1995-05-16 Toray Ind Inc 心不全治療剤
JP3541417B2 (ja) * 1994-02-24 2004-07-14 日産化学工業株式会社 フェニル置換ヒドロキシシクロペンテノン類、ペンタノン類及びフェニル置換プロスタグランジンｉ２類中間体並びにその製造法及び光学分割法
DE69713271T2 (de) * 1996-09-17 2002-09-26 Toray Industries Verstärker der blutplättchenfunktionund verfahren zur behandlung der blut plättchenfunktionsstörung
EP0925787A4 (de) * 1997-02-27 1999-12-01 Toray Industries Arzneimittel zur verbesserung des lungkreislaufs
DE69834262T2 (de) * 1997-09-16 2006-09-07 Toray Industries, Inc. C-C Chemokine Produktionsinhibitoren
JPH11228417A (ja) * 1998-02-06 1999-08-24 Teijin Ltd 神経障害治療剤
US20030092760A1 (en) * 2001-03-12 2003-05-15 Toray Industries, Inc. Therapeutic agent for renal failure
CA2382759A1 (en) * 1999-08-05 2001-02-15 Teijin Limited Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient
CN105315247B (zh) * 2011-06-16 2019-07-26 琅歌生物技术股份有限公司 贝前列素的生产方法
CN110452100A (zh) * 2019-07-31 2019-11-15 济南康和医药科技有限公司 一种贝前列素钠中间体的合成方法
CN110746450A (zh) * 2019-09-17 2020-02-04 济南康和医药科技有限公司 一种贝前列素钠关键中间体的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5931510B2 (ja) * 1979-09-03 1984-08-02 東レ株式会社 ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
JPS5732277A (en) * 1980-08-05 1982-02-20 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative
JPS57144276A (en) * 1981-03-03 1982-09-06 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative

Also Published As

Publication number Publication date
JPH0257548B2 (de) 1990-12-05
EP0060640B1 (de) 1985-11-13
JPS57144276A (en) 1982-09-06
US4564620A (en) 1986-01-14
DK84082A (da) 1982-09-04
AU560140B2 (en) 1987-04-02
EP0060640A1 (de) 1982-09-22
US4822804A (en) 1989-04-18
ZA821403B (en) 1983-01-26
AU8107182A (en) 1982-09-09

Similar Documents

Publication Publication Date Title
DE3267350D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them
IL66501A (en) Benzazepine-2-one derivatives,their manufacture and pharmaceutical compositions containing them
IL65257A0 (en) Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them
IL65803A (en) Cyclobutene-dione derivatives,their preparation and pharmaceutical compositions containing them
DE3265978D1 (en) 1,4-dihydropyridine derivative and pharmaceutical composition containing same
IL65076A (en) 3,4-dihydro-5h-2,3-benzo-diazepine derivatives,their preparation and pharmaceutical compositions containing them
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
IL64777A0 (en) 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them
ZA824622B (en) Pharmaceutical compositions
IL66408A (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
DE3064582D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives and pharmaceutical compositions containing them
IL67180A0 (en) Morphinate derivatives,their preparation and pharmaceutical compositions containing them
DE3275296D1 (en) Azabicyclo-(3,3,1)-nonylbenzamide derivatives, processes for their preparation, and pharmaceutical compositions containing them
DE3270202D1 (en) 3,5-di-tert-butylstyrene derivatives, processes for their preparations, and pharmaceutical compositions containing them
IL65327A0 (en) Acylquinolinone derivatives,their preparation and pharmaceutical compositions containing them
ZA825397B (en) Pharmaceutical compositions
IL66424A (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
ZA822856B (en) Pharmaceutical compositions
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
IL66238A0 (en) Benzothiazolesulfonamide derivatives,their preparation and pharmaceutical compositions containing them
IL65422A (en) 2-piperazino-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ZA82652B (en) Pharmaceutical compositions
DE3268487D1 (en) 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives, their preparation and pharmaceutical compositions
IL65965A0 (en) 4-amino-benzylamine derivatives,their preparation and pharmaceutical compositions containing them
KE3739A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition